Yubo International Biotech Limited (YBGJ)
OTCMKTS · Delayed Price · Currency is USD
0.0210
-0.0144 (-40.68%)
Aug 29, 2025, 3:48 PM EDT

YBGJ Statistics

Total Valuation

YBGJ has a market cap or net worth of 3.58 million. The enterprise value is 7.36 million.

Market Cap3.58M
Enterprise Value 7.36M

Important Dates

The last earnings date was Monday, August 11, 2025.

Earnings Date Aug 11, 2025
Ex-Dividend Date n/a

Share Statistics

YBGJ has 170.42 million shares outstanding. The number of shares has increased by 900.00% in one year.

Current Share Class 170.42M
Shares Outstanding 170.42M
Shares Change (YoY) +900.00%
Shares Change (QoQ) n/a
Owned by Insiders (%) 67.41%
Owned by Institutions (%) n/a
Float 14.99M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio -198,824.28
PB Ratio -0.90
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -5.21
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.13

Current Ratio 0.13
Quick Ratio 0.08
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -70.42%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) 39.41%
Revenue Per Employee -1
Profits Per Employee -78,420
Employee Count18
Asset Turnover n/a
Inventory Turnover 1.35

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -92.58% in the last 52 weeks. The beta is 0.78, so YBGJ's price volatility has been lower than the market average.

Beta (5Y) 0.78
52-Week Price Change -92.58%
50-Day Moving Average 0.06
200-Day Moving Average 0.06
Relative Strength Index (RSI) 38.73
Average Volume (20 Days) 175,193

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 0.26

Income Statement

In the last 12 months, YBGJ had revenue of -18 and -1.41 million in losses. Loss per share was -0.01.

Revenue-18
Gross Profit -84,041
Operating Income -1.57M
Pretax Income -1.57M
Net Income -1.41M
EBITDA -1.39M
EBIT -1.57M
Loss Per Share -0.01
Full Income Statement

Balance Sheet

The company has 10,416 in cash and 3.77 million in debt, giving a net cash position of -3.76 million or -0.02 per share.

Cash & Cash Equivalents 10,416
Total Debt 3.77M
Net Cash -3.76M
Net Cash Per Share -0.02
Equity (Book Value) -3.98M
Book Value Per Share -0.03
Working Capital -4.37M
Full Balance Sheet

Cash Flow

Operating Cash Flow -934,381
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin 8,701,022.22%
Pretax Margin 8,700,416.67%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

YBGJ does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -900.00%
Shareholder Yield n/a
Earnings Yield -39.44%
FCF Yield n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

YBGJ has an Altman Z-Score of -17.74 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -17.74
Piotroski F-Score 2